| Serial Number | 90340401 |
| Word Mark | SIO GENE THERAPIES |
| Filing Date | Tuesday, November 24, 2020 |
| Status | 605 - ABANDONED - EXPRESS AFTER PUB |
| Status Date | Thursday, January 26, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 28, 2021 |
| Goods and Services | Pharmaceutical preparations for human use used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments; biologic preparations for medical and therapeutic purposes used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments |
| Goods and Services | Providing health and medical information; providing medical and health information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; all of the foregoing used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and antiaging and anti-wrinkle skin care prevention preparations and treatments |
| Disclaimer with Predetermined Text | "GENE THERAPIES" |
| Goods and Services | Scientific and technological services and research and design relating thereto in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; pharmaceutical, biomedical and biological therapeutic research services in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; pharmaceutical research and development in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; all of the foregoing excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Thursday, January 26, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Thursday, January 26, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Thursday, January 26, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sio Gene Therapies Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10036 |
| Party Name | Sio Gene Therapies Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10036 |
| Event Date | Event Description |
| Thursday, January 26, 2023 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION |
| Thursday, January 26, 2023 | ABANDONMENT - AFTER PUBLICATION |
| Wednesday, January 25, 2023 | TEAS EXPRESS ABANDONMENT RECEIVED |
| Tuesday, August 23, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, August 19, 2022 | SOU EXTENSION 1 GRANTED |
| Friday, August 19, 2022 | SOU EXTENSION 1 FILED |
| Friday, August 19, 2022 | TEAS EXTENSION RECEIVED |
| Tuesday, February 22, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 1, 2022 | REVIEW OF CORRESPONDENCE COMPLETE |
| Tuesday, February 1, 2022 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Monday, January 31, 2022 | ASSIGNED TO PETITION STAFF |
| Thursday, January 20, 2022 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Wednesday, January 19, 2022 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Tuesday, December 28, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 28, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 8, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, November 22, 2021 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, November 19, 2021 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, November 17, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, November 11, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 10, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 10, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 12, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, May 12, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, May 12, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, May 10, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, May 10, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, May 10, 2021 | NON-FINAL ACTION WRITTEN |
| Saturday, May 8, 2021 | ASSIGNED TO EXAMINER |
| Saturday, January 30, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 27, 2020 | NEW APPLICATION ENTERED |